Advanced search
Publication Cover
Emerging Microbes & Infections Volume 4, 2015 - Issue 1
Submit an article Journal homepage
1,144
Views
33
CrossRef citations to date
0
Altmetric
Original Articles

Sphingosine kinase 2 is a chikungunya virus host factor co-localized with the viral replication complex

St Patrick ReidMolecular and Translational Science, US Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, MD21702-5011, USA
,
Sarah R TritschMolecular and Translational Science, US Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, MD21702-5011, USA
,
Krishna KotaMolecular and Translational Science, US Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, MD21702-5011, USA;Perkin Elmer, Waltham, MA02451, USA
,
Chih-Yuan ChiangMolecular and Translational Science, US Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, MD21702-5011, USA
,
Lian DongMolecular and Translational Science, US Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, MD21702-5011, USA
,
Tara KennyMolecular and Translational Science, US Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, MD21702-5011, USA
,
Ernest E BrueggemannMolecular and Translational Science, US Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, MD21702-5011, USA
,
Michael D WardMolecular and Translational Science, US Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, MD21702-5011, USA
,
Lisa H CazaresMolecular and Translational Science, US Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, MD21702-5011, USA
&
Sina BavariMolecular and Translational Science, US Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, MD21702-5011, USACorrespondence[email protected]
 show all
Pages 1-9 | Received 05 Feb 2015, Accepted 27 Jul 2015, Published online: 25 Jan 2019

  • Brighton SW, Prozesky OW, de la Harpe AL.Chikungunya virus infection. A retrospective study of 107 cases. S Afr Med J 1983;63: 313–315.
  • Kennedy AC, Fleming J, Solomon L.Chikungunya viral arthropathy: a clinical description. J Rheumatol 1980;7: 231–236.
  • Mohan A, Kiran DH, Manohar IC et al.Epidemiology, clinical manifestations, and diagnosis of Chikungunya fever: lessons learned from the re-emerging epidemic. Indian J Dermatol 2010;55: 54–63.
  • Schilte C, Staikowsky F, Couderc T et al.Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study. PLoS Negl Trop Dis 2013;7: e2137.
  • Weaver SC.Arrival of chikungunya virus in the new world: prospects for spread and impact on public health. PLoS Negl Trop Dis 2014;8: e2921.
  • Jones PH, Maric M, Madison MN et al.BST-2/tetherin-mediated restriction of chikungunya (CHIKV) VLP budding is counteracted by CHIKV non-structural protein 1 (nsP1). Virology 2013;438: 37–49.
  • Schilte C, Couderc T, Chretien F et al.Type I IFN controls chikungunya virus via its action on nonhematopoietic cells. J Exp Med 2010;207: 429–442.
  • Werneke SW, Schilte C, Rohatgi A et al.ISG15 is critical in the control of Chikungunya virus infection independent of UbE1L mediated conjugation. PLoS Pathog 2011;7: e1002322.
  • Lum FM, Ng LF.Cellular and molecular mechanisms of chikungunya pathogenesis. Antiviral Res 2015;120: 165–174.
  • Abere B, Wikan N, Ubol S et al.Proteomic analysis of chikungunya virus infected microglial cells. PLoS One 2012;7: e34800.
  • Dhanwani R, Khan M, Alam SI et al.Differential proteome analysis of Chikungunya virus-infected new-born mice tissues reveal implication of stress, inflammatory and apoptotic pathways in disease pathogenesis. Proteomics 2011;11: 1936–1951.
  • Tchankouo-Nguetcheu S, Khun H, Pincet L et al.Differential protein modulation in midguts of Aedes aegypti infected with chikungunya and dengue 2 viruses. PLoS One 2010;5: pii: e13149.
  • Thio CL, Yusof R, Abdul-Rahman PS et al.Differential proteome analysis of chikungunya virus infection on host cells. PLoS One 2013;8: e61444.
  • Bourai M, Lucas-Hourani M, Gad HH et al.Mapping of Chikungunya virus interactions with host proteins identified nsP2 as a highly connected viral component. J Virol 2012;86: 3121–3134.
  • Dudha N, Rana J, Rajasekharan S et al.Host-pathogen interactome analysis of Chikungunya virus envelope proteins E1 and E2. Virus Genes 2015;50: 200–209.
  • Fros JJ, Domeradzka NE, Baggen J et al.Chikungunya virus nsP3 blocks stress granule assembly by recruitment of G3BP into cytoplasmic foci. J Virol 2012;86: 10873–10879.
  • Panas MD, Ahola T, McInerney GM.The C-terminal repeat domains of nsP3 from the Old World alphaviruses bind directly to G3BP. J Virol 2014;88: 5888–5893.
  • Scholte FE, Tas A, Albulescu IC et al.Stress granule components G3BP1 and G3BP2 play a proviral role early in Chikungunya virus replication. J Virol 2015;89: 4457–4469.
  • Spiegel S, Milstien S.Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 2003;4: 397–407.
  • Maceyka M, Harikumar KB, Milstien S et al.Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol 2012;22: 50–60.
  • Spiegel S, Milstien S.The outs and the ins of sphingosine-1-phosphate in immunity. Nat Rev Immunol 2011;11: 403–415.
  • Monick MM, Cameron K, Powers LS et al.Sphingosine kinase mediates activation of extracellular signal-related kinase and Akt by respiratory syncytial virus. Am J Respir Cell Mol Biol 2004;30: 844–852.
  • Carr JM, Mahalingam S, Bonder CS et al.Sphingosine kinase 1 in viral infections. Rev Med Virol 2013;23: 73–84.
  • Seo YJ, Blake C, Alexander S et al.Sphingosine 1-phosphate-metabolizing enzymes control influenza virus propagation and viral cytopathogenicity. J Virol 2010;84: 8124–8131.
  • Seo YJ, Pritzl CJ, Vijayan M et al.Sphingosine kinase 1 serves as a pro-viral factor by regulating viral RNA synthesis and nuclear export of viral ribonucleoprotein complex upon influenza virus infection. PLoS One 2013;8: e75005.
  • Vijayan M, Seo YJ, Pritzl CJ et al.Sphingosine kinase 1 regulates measles virus replication. Virology 2014;450–451: 55–63.
  • Carr JM, Kua T, Clarke JN et al.Reduced sphingosine kinase 1 activity in dengue virus type-2 infected cells can be mediated by the 3′ untranslated region of dengue virus type-2 RNA. J Gen Virol 2013;94: 2437–2448.
  • Yamane D, Zahoor MA, Mohamed YM et al.Inhibition of sphingosine kinase by bovine viral diarrhea virus NS3 is crucial for efficient viral replication and cytopathogenesis. J Biol Chem 2009;284: 13648–13659.
  • Yamane D, McGivern DR, Wauthier E et al.Regulation of the hepatitis C virus RNA replicase by endogenous lipid peroxidation. Nat Med 2014;20: 927–935.
  • Dai L, Plaisance-Bonstaff K, Voelkel-Johnson C et al.Sphingosine kinase-2 maintains viral latency and survival for KSHV-infected endothelial cells. PLoS One 2014;9: e102314.
  • Jao CY, Salic A.Exploring RNA transcription and turnover in vivo by using click chemistry. Proc Natl Acad Sci USA 2008;105: 15779–15784.
  • Bader GD, Hogue CW.An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics 2003;4: 2.
  • Ceol A, Chatr Aryamontri A, Licata L et al.MINT, the molecular interaction database: 2009 update. Nucleic Acids Res 2010;38: D532–D539.
  • Croft D, O’Kelly G, Wu G et al.Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res 2011;39: D691–D697.
  • Peri S, Navarro JD, Amanchy R et al.Development of human protein reference database as an initial platform for approaching systems biology in humans. Genome Res 2003;13: 2363–2371.
  • Ruepp A, Waegele B, Lechner M et al.CORUM: the comprehensive resource of mammalian protein complexes – 2009. Nucleic Acids Res 2010;38: D497–D501.
  • Shannon P, Markiel A, Ozier O et al.Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003;13: 2498–2504.
  • French KJ, Schrecengost RS, Lee BD et al.Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res 2003;63: 5962–5969.
  • Orr Gandy KA, Obeid LM.Targeting the sphingosine kinase/sphingosine 1-phosphate pathway in disease: review of sphingosine kinase inhibitors. Biochim Biophys Acta 2013;1831: 157–166.
  • Gao P, Peterson YK, Smith RA et al.Characterization of isoenzyme-selective inhibitors of human sphingosine kinases. PLoS One 2012;7: e44543.
  • French KJ, Zhuang Y, Maines LW et al.Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2. J Pharmacol Exp Ther 2010;333: 129–139.
  • Ding G, Sonoda H, Yu H et al.Protein kinase D-mediated phosphorylation and nuclear export of sphingosine kinase 2. J Biol Chem 2007;282: 27493–27502.
  • Igarashi N, Okada T, Hayashi S et al.Sphingosine kinase 2 is a nuclear protein and inhibits DNA synthesis. J Biol Chem 2003;278: 46832–46839.
  • Neubauer HA, Pitson SM.Roles, regulation and inhibitors of sphingosine kinase 2. FEBS J 2013;280: 5317–5336.
  • Couderc T, Chretien F, Schilte C et al.A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease. PLoS Pathog 2008;4: e29.
  • Ozden S, Huerre M, Riviere JP et al.Human muscle satellite cells as targets of Chikungunya virus infection. PLoS One 2007;2: e527.
  • Hait NC, Allegood J, Maceyka M et al.Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. Science 2009;325: 1254–1257.
  • Hait NC, Bellamy A, Milstien S et al.Sphingosine kinase type 2 activation by ERK-mediated phosphorylation. J Biol Chem 2007;282: 12058–12065.
  • Leclercq TM, Moretti PA, Vadas MA et al.Eukaryotic elongation factor 1A interacts with sphingosine kinase and directly enhances its catalytic activity. J Biol Chem 2008;283: 9606–9614.
  • Frolova EI, Gorchakov R, Pereboeva L et al.Functional Sindbis virus replicative complexes are formed at the plasma membrane. J Virol 2010;84: 11679–11695.
  • Kujala P, Ikaheimonen A, Ehsani N et al.Biogenesis of the Semliki Forest virus RNA replication complex. J Virol 2001;75: 3873–3884.
  • Rikkonen M, Peranen J, Kaariainen L.Nuclear and nucleolar targeting signals of Semliki Forest virus nonstructural protein nsP2. Virology 1992;189: 462–473.
  • Finnegan CM, Rawat SS, Puri A et al.Ceramide, a target for antiretroviral therapy. Proc Natl Acad Sci USA 2004;101: 15452–15457.
  • Voisset C, Lavie M, Helle F et al.Ceramide enrichment of the plasma membrane induces CD81 internalization and inhibits hepatitis C virus entry. Cell Microbiol 2008;10: 606–617.
  • Jan JT, Chatterjee S, Griffin DE.Sindbis virus entry into cells triggers apoptosis by activating sphingomyelinase, leading to the release of ceramide. J Virol 2000;74: 6425–6432.
  • Nieva JL, Bron R, Corver J et al.Membrane fusion of Semliki Forest virus requires sphingolipids in the target membrane. EMBO J 1994;13: 2797–2804.
  • Wati S, Rawlinson SM, Ivanov RA et al.Tumour necrosis factor alpha (TNF-alpha) stimulation of cells with established dengue virus type 2 infection induces cell death that is accompanied by a reduced ability of TNF-alpha to activate nuclear factor kappaB and reduced sphingosine kinase-1 activity. J Gen Virol 2011;92: 807–818.
  • Machesky NJ, Zhang G, Raghavan B et al.Human cytomegalovirus regulates bioactive sphingolipids. J Biol Chem 2008;283: 26148–26160.
  • Rana J, Sreejith R, Gulati S et al.Deciphering the host-pathogen protein interface in chikungunya virus-mediated sickness. Arch Virol 2013;158: 1159–1172.
  • Pitson SM, Xia P, Leclercq TM et al.Phosphorylation-dependent translocation of sphingosine kinase to the plasma membrane drives its oncogenic signalling. J Exp Med 2005;201: 49–54.
  • Gorchakov R, Garmashova N, Frolova E et al.Different types of nsP3-containing protein complexes in Sindbis virus-infected cells. J Virol 2008;82: 10088–10101.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.